Cargando...
NT-20 TARGETING CDK4 AND 6 IN THE CLASSICAL SUBTYPE OF GLIOBLASTOMA
BACKGROUND: Glioblastoma is highly refractory to conventional treatment approaches. Since the introduction of concomitant and adjuvant temozolomide and radiotherapy, patients with glioblastoma have shown little improvement in the median survival time of just 15 months. Inhibitors that target the cel...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Oxford University Press
2014
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4218427/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou265.18 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|